Farnesol for aerosol inhalation: Nebulization and activity against human lung cancer cells

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 1, 2003, Pages 95-100

  Wang, Z ^a   Chen, H T ^a   Roa, W ^a   Finlay, Warren H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOL; POLYSORBATE 80;

AEROSOL; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DEVICE; DRUG FORMULATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CANCER; MATHEMATICAL MODEL; NEBULIZATION; NEBULIZER; TRACHEOBRONCHIAL TREE;

ADMINISTRATION, INHALATION; AEROSOLS; ANTINEOPLASTIC AGENTS; CELL DEATH; COMPUTER SIMULATION; FARNESOL; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TUMOR CELLS, CULTURED;

EID: 0037711373     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sharma, S., White, D., Imondi, A.R., Placke M. E., Vail, D. M. and Kris M.G., Development of inhalation agents for oncology use. Journal of Clinical Oncology, 19: 1839-1847, 2001
2. Placke, M.E., Zimlich, W.C., Ding, J. Y., Westaway, D. J. and Imondi, A. R., Targeted aerosol therapy for the treatment of lung cancer. Respiratory Drug Delivery VIII, Tucson, Arizona, USA, 15-23, 2002.
3. Burke, Y.D., Stark, M. J., Roach, S.L., Sen, S.E. and Crowell, P. L., Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids, 32: 151-156, 1997.
4. Vigushin, D.M., Poon, G. K., Boddy, A., English, J., Halbert, G. W., Pagonis, C., Jarman, M. and Coombes, R.C., Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Chemother. Pharmacol, 42: 111-117,1998.
5. Ripple, G. H., Gould, M. N., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Simon, K., Binger, K., Tutsch, K. D., Pomplun, M., Wahamaki, A., Marnocha, R., Wilding, G. and Bailey, H.H., Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clinical Cancer Research, 6: 390-396,2000.
6. Hudes, G. R., Szarka, C. E., Adams, A., Ranganathan, S., McCauley, R. A., Weiner, L. M., Langer, C. J., Litwin, S., Yeslow, G., Halberr, T., Qian, M. and Gallo, J. M., Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in Patients with refractory solid malignancies. Clinical Cancer Research, 6: 3021-3080, 2000.
7. Elson, C. E., Peffley, D.M., Hentosh, P. and Mo, H., Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proceedings of The Society for Experimental Biology and Medicine, 221: 294-311, 1999.
8. Tatman, D., and Mo, H., Volatile isoprenoid constituents of fruits, vegetables, and herbs cumulatively suppress the proliferations of murine b16 melanoma and human HL-60 leukemia cells. Cancer Letters, 175: 129-139, 2002.
9. Rioja, A., Pizzey, A. P., Marson, C. M. and Thomas, N. S. B., Preferential induction of apoptosis of leukaemic cells by farnesol. FEBS Letters, 467: 291-295, 2000.
10. Anthony, M.L., Zhao, M. and Brindle, K. M., Inhibition of phosphatidylcholine Biosystheis following induction of apoptosis in HL-60 cells. The journal of Biological Chemistry, 274: 19686-19692, 1999.
11. Elson, C. E., Peffley, D. M., Hentosh, P. And Mo, H., Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer (Minireview). Proceedings of the Society for Experimental Biology and Medicine, 221:294-311, 1999.
12. Sharma, S., White, D., Imondi, A. R., Placke, M. E., Vail, D. M. and Kris, M. G., Development of inhalation agents for oncology use. J. Clinical Oncology, 19(6):1839-1847, 2001.
13. Miquel, K., Pradines, A. and Favre, G., Farnesol and geranylgeraniol induce acting cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochemical and Biophysical Research Communications, 225: 869-876, 1996.
14. Miquel, K., Pradines, A., Tercé, F., Selmi, S. and Favre, G., Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung ademocarcinoma A549 cells. The Journal of Biological Chemistry, 40: 26179-26186, 1998.
15. Prokop, R. M., Finlay, W. H. and Stapleton, K. W., An in vitro technique for calculating the regional dosages of drugs delivered by an ultrasonic nebulizer. J. Aerosol Sci., 26: 847-860, 1995.
16. Diot, P., Dequin, P. F., Rivoire, B., Gagnadoux, F., Faurisson, F., Diot, E., Boissinot, E., Le Pape, A., Palmer, L. and Lemarié, E., Aerosols and Anti-infectious Agents. Journal of aerosol medicine, 14: 55-64, 2001.
17. Lange, C. F., Hancock, R. E. W., Samuel, J. and Finlay, W. H., In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. J. Pharmaceutical Sci., 10:1647-1657, 2001.
18. Finlay, W. H., Lange, C. F., King, M. and Speert, D. P., Lung delivery of aerosolized dextran. Am J. Respir Crit Care Med., 161:121-127, 2000.
19. Chan, T. L. and Lippmann, M., Experimental measurements and empirical modeling of the regional deposition of inhaled particles in humans. Am Ind. Hyg. Assoc. J., 41:399-409, 1980
20. Pich, J., Theory of gravitational deposition of particles from laminar flows in channels. J. Aerosol Sci., 3:351-361, 1972.
21. Heyder, J. and Gebhart, J., Gravitational deposition of particles from laminar aerosol flow through inclined circular tubes. J. Aerosol Sci., 6:311-328, 1977.
22. Gormley P. G. and Kennedy, K., Diffusion from a steam flowing through a cylindrical tube. Proc. R. Irish Soc., 52A:163, 1949.
23. Finlay, W. H., Estimating the type of hygroscopic behavior exhibited by aqueous droplets. J. Aerosol Med., 11:221-229, 1998.
24. Wanner, A., Salathé, M., O'Riordan, T. G., Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med., 154:1868-190, 1996.